Latest Breaking News On - Department of clinical neurosciences - Page 6 : comparemela.com

Olatec Therapeutics to Conduct a Phase 2 Clinical Trial in Patients with Early Parkinson s Disease with its NLRP3 Inhibitor, Dapansutrile

Olatec Therapeutics, Inc. (Olatec), a leader in the developing class of selective NLRP3 inhibitors, today announced that Cure Parkinson's granted an award to initiate a Phase 2 clinical trial investigating the potential of oral dapansutrile to slow.

United kingdomCity ofDamaris skourasQueen squareCaroline williams grayCarolineh williams grayProduct serviceJohn black charitable foundationDepartment of clinical neurosciencesOxford clinical schoolUniversity of cambridgeVan andel instituteInternational linked clinical trialsCambridge universityJohn van geest centre for brainOlatec therapeutics inc

Alarm as cost of lessons to be learnt Scots inquiries soars to £120m

The public cost of lessons to be learnt public inquiries in Scotland has soared sixfold over ten years to over £120m leading to new concerns…

United kingdomCity ofSierra leoneGlasgow cityNicola sturgeonHumza yousafSheku bayohJohn chilcotLady smithJohn swinneyAlastair bonningtonJeane freemanJoanna marchongLady pooleUniversity of glasgowQueen elizabeth university hospital

Alarm over spiralling £120m cost of Scots public inquiries

The public cost of lessons to be learnt public inquiries in Scotland has soared sixfold over ten years to over £120m leading to new concerns…

United kingdomGlasgow citySierra leoneCity ofJeane freemanSheku bayohNicola sturgeonLady smithJohn swinneyLady pooleJoanna marchongHumza yousafAlastair bonningtonJohn chilcotEdinburgh international conference centreCity of edinburgh council

Evidence of brain ability to compensate for age-related deterioration

Evidence of brain ability to compensate for age-related deterioration
plenglish.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plenglish.com Daily Mail and Mail on Sunday newspapers.

United kingdomEast sussexAlexa morcomBethan knightsKamen tsvetanovAlzheimer society dementia research leaderCambridge centre for ageing neuroscienceUniversity of sussexUniversity of cambridgeResearch council cognitionBrain sciences unit at cambridgeUniversity of sussex school psychologyDepartment of clinical neurosciencesSociety dementia research leader fellowClinical neurosciencesCambridge centre

Our Brains Can Compensate for Cognitive Decline

Scientists have found the strongest evidence yet that our brains can compensate for age-related deterioration by recruiting other areas to help with brain function and maintain cognitive performance.

East sussexUnited kingdomAlexa morcomBethan knightsKamen tsvetanovCambridge centre for ageing neuroscienceResearch council cognitionAlzheimer society dementia research leaderTechnology networkBrain sciences unit at cambridgeUniversity of sussex school psychologyDepartment of clinical neurosciencesUniversity of sussexUniversity of cambridgeSociety dementia research leader fellowClinical neurosciences